Cabaletta Bio, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.37 | $-0.34 | +8.1% | Beat |
| Q12026 FY2026 | $-0.41 | $-0.39 | +4.9% | Beat |
| Q42025 FY2025 | $-0.45 | $-0.40 | +11.1% | Beat |
Back to CABA overview · CABA holders · CABA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.